Venus Remedies Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock of Venus Remedies Ltd hit its upper circuit at Rs 1856.5, marking a 5.0% gain within the 5% price band allowed for the day. This price band capped the maximum daily gain, effectively freezing trading at the ceiling price. The exchange ceiling stopped the rally, not the buyers, indicating that demand exceeded what the price band could accommodate. The total traded volume was 0.34688 lakh shares, with a turnover of ₹6.38 crore, reflecting the mechanical suppression of volume typical on circuit days. Venus Remedies Ltd’s session was characterised by unfilled demand, as no sellers were willing to transact at prices below the circuit limit — a hallmark of strong buying interest.

Delivery and Volume Analysis

Despite the upper circuit, delivery volumes tell a more nuanced story. On 23 Jun 2026, the delivery volume was 5,260 shares, which represents a sharp decline of 57.33% against the 5-day average delivery volume. This fall in delivery volume suggests that the recent surge may be driven more by speculative buying rather than long-term accumulation. Volume on a circuit day is mechanically suppressed because the price lock reduces liquidity, which means demand likely exceeded what the traded volume reflects — what does the full demand picture look like for Venus Remedies Ltd once the circuit unlocks and normal trading resumes? However, the drop in delivery volume tempers the conviction narrative, indicating that while buyers are eager, the commitment to hold shares may be limited.

Moving Averages and Trend Context

Venus Remedies Ltd is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages — signalling a strong bullish trend. The stock’s position above these averages confirms that the recent price action is consistent with an established upward momentum rather than a sudden spike. The circuit day added 5.0% to the price, reinforcing the trend confirmation. The stock is also trading close to its 52-week high, just 4.7% shy of Rs 1943.8, which adds to the technical strength. This alignment of moving averages with the circuit event suggests that the rally is supported by a positive trend structure, though the delivery data invites caution.

Liquidity and Market Capitalisation Context

With a market capitalisation of approximately ₹2,421 crore, Venus Remedies Ltd is classified as a micro-cap stock. This segment is known for thinner liquidity and more pronounced price swings, making upper circuits more common and impactful. The stock’s liquidity profile shows it is liquid enough for a trade size of ₹0.25 crore, based on 2% of the 5-day average traded value. While this suggests some capacity for institutional participation, the limited trade size highlights the liquidity risk inherent in micro-cap stocks. The upper circuit is impressive, but the ability to enter or exit a position of meaningful size is constrained by the thin order book — should investors be cautious about liquidity risk when chasing such moves?

Intraday Price Action

The intraday range on 24 Jun 2026 was relatively narrow, with a low of Rs 1770.1 and a high of Rs 1856.5, the circuit price. The stock touched the upper circuit after a steady recovery from the day’s low, indicating sustained buying pressure throughout the session. Circuit stocks often exhibit such narrow ranges near the ceiling price, as the price band restricts upward movement. The total traded volume was lower than usual, a mechanical consequence of the circuit lock, but the turnover of ₹6.38 crore reflects active participation within the permitted price range.

Brief Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by steady demand and innovation-driven growth. The stock has outperformed its sector by 4.73% on the day, while the Sensex gained 0.51%, highlighting relative strength. The company’s recent two-day gain of 9.73% reflects positive momentum, though the delivery volume decline suggests that the rally may be more speculative than fundamental at this juncture.

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at Rs 1856.5 capped a 5.0% gain for Venus Remedies Ltd, with unfilled demand evident as buyers outnumbered sellers at the ceiling price. However, the sharp decline in delivery volume by 57.33% tempers the conviction narrative, suggesting that much of the buying may be speculative or intraday in nature rather than long-term accumulation. The stock’s position above all major moving averages confirms a bullish trend, but the micro-cap status and limited liquidity introduce significant risk for investors attempting to enter or exit sizeable positions. The intraday price action and turnover reflect active but constrained trading, typical of circuit days in smaller stocks. Taken together, these factors highlight a momentum-driven move with liquidity caveats — after a 5.0% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?